Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.
Saved in:
| Title: | Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial. |
|---|---|
| Authors: | Preston, Ioana R.1 (AUTHOR) ipreston@tuftsmedicalcenter.org, Burger, Charles D.2 (AUTHOR), Bartolome, Sonja3 (AUTHOR), Safdar, Zeenat4 (AUTHOR), Krowka, Michael5 (AUTHOR), Sood, Namita6 (AUTHOR), Ford, Hubert J.7 (AUTHOR), Battarjee, Wejdan F.1 (AUTHOR), Chakinala, Murali M.8 (AUTHOR), Gomberg-Maitland, Mardi9 (AUTHOR), Hill, Nicholas S.1 (AUTHOR) |
| Source: | Journal of Heart & Lung Transplantation. May2020, Vol. 39 Issue 5, p464-472. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10532498 |
|---|---|
| DOI: | 10.1016/j.healun.2019.12.008 |
